CD4+CD25high regulatory cells in human peripheral blood.

Area of Science:

• Immunology
• Autoimmunity
• T cell biology

Background:

• Neonatal thymectomy in mice causes autoimmune disease by depleting regulatory T cells.
• CD4(+)CD25(+) T cells are critical for immune tolerance and preventing autoimmunity.

Purpose of the Study:

• To identify and characterize human regulatory T cells analogous to murine CD4(+)CD25(+) regulatory T cells.
• To investigate the function and suppressive mechanisms of human CD4(+)CD25(high) regulatory T cells.

Main Methods:

• Isolation and characterization of human CD4(+) T cell subsets based on CD25 expression.
• In vitro co-culture assays to assess T cell proliferation and cytokine secretion.
• Analysis of T cell surface marker expression (CD45RO, CD45RA).
• Investigation of regulatory T cell function under varying stimulation conditions and blockade of co-stimulatory pathways (PD-1/PD-L1, CTLA-4/B7).

Main Results:

• A population of human CD4(+)CD25(high) T cells was identified with regulatory functions similar to murine CD4(+)CD25(+) T cells.
• These human regulatory T cells suppressed proliferation and cytokine secretion of CD4(+)CD25(-) responder T cells in a contact-dependent manner.
• Regulatory function persisted even when PD-1/PD-L1 or CTLA-4/B7 pathways were blocked.
• Human CD4(+)CD25(high) T cells expressed CD45RO, similar to CD45RB(low) expression in mice.

Conclusions:

• Human circulation contains CD4(+)CD25(high) regulatory T cells that play a role in immune suppression.
• These cells offer a potential target for understanding and treating human autoimmune diseases.
• Further research is warranted to explore the involvement of these regulatory T cells in human autoimmune disorders.